C-Terminal Fragments of gpl20 and Synthetic Peptides from Five HTLV-III Strains: Prevalence of Antibodies to the HTLV-III-MN Isolate in Infected Individuals-Reference-Cited by-同舟云学术

C-Terminal Fragments of gpl20 and Synthetic Peptides from Five HTLV-III Strains: Prevalence of Antibodies to the HTLV-III-MN Isolate in Infected Individuals

Published:1990-03 Issue:3 Volume:6 Page:307-316
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

DEVASH YAIR,MATTHEWS THOMAS J.,DRUMMOND JAMES E.,JAVAHERIAN KASHI,WATERS DAVID J.,ARTHUR LARRY O.,BLATTNER WILLIAM A.,RUSCHE JAMES R.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.1990.6.307

Reference9 articles.

1. HTLV-III/LAV-Neutralizing Antibodies to an E. coli -Produced Fragment of the Virus Envelope

2. Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells.

3. Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.

4. Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120.

5. Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees.

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modifications of Hiv-1 Retrovirus-like Particles to Enhance Safety and Immunogenicity;Biologicals;1998-12

2. Epitope map of human immunodeficiency virus type 1 gp41 derived from 47 monoclonal antibodies produced by immunization with oligomeric envelope protein;Journal of Virology;1997-04

3. Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein;Journal of Virology;1996-02

4. Efficient replication of human immunodeficiency virus type 1 and measles virus in a human-to-mouse graft versus host disease model permits immunization research;Journal of General Virology;1995-11-01

5. Continuity and Discontinuity in the Anti-V3 IgG Response of Human Immunodeficiency Virus Type 1-Infected Persons in a Cross-Sectional and Longitudinal Study Using Synthetic Peptides;Journal of Infectious Diseases;1995-09-01